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Resting state fcMRI networks resemble 
task activation and anatomical networks 
4 RSNA—Personal Learning in the 
Global Community 
The Radiological Society of North 
America's 94th annual meeting 
included nearly 70 presentations 
by Mallinckrodt Institute faculty 
and staff. 
9 To Catch a Cancer: A New Era 
in Colorectal Cancer Screening 
Published results of the National 
CT Colonography Trial show that 
virtual colonoscopy is as effective 
as conventional colonoscopy in 
the detection of early-stage col- 
orectal cancers. 
14A Leg to Stand On 
If an innovative procedure using 
image-guided catheters can success- 
fully remove blood clots associated 
with deep vein thrombosis, it could 
be a powerful complement to anti- 
coagulant therapy. 
ON THE COVER Suresh Vedantham, MD, is directing 
an NIH-sponsored trial, involving ISO researchers 
nationwide, to investigate a promising treatment of 
deep vein thrombosis.   Photograph by Tim Parker. 
19 First MIR Research 
Poster Session 
The Division of Radiological 
Sciences' poster exposition high- 
lighted imaging research from 
"molecule to mouse to man." 
i Improving Medical Response to 
Stroke Symptoms 
Washington University Medical 
Center is one of eight facilities 
that will establish a program 
(called SPOTRIAS) for earlier, 
more effective ways to diagnose 
and treat strokes. 
The Traumatic Brain Injury 
Conference 
Experts involved in the study and 
treatment of blast-related brain injury 
met in St. Louis to discuss their clini- 





Marcus Raichle, MD, professor of radiology, of neurology, 
of neurobiology, and of biomedical engineering, was one of 
two recipients of the 2009 Ralph W. Gerard Prize in Neuro- 
science, presented by the Society for Neuroscience (SfN). 
The award, named after Ralph Gerard, PhD, a neurophysiologist 
and behavioral scientist, recognizes Raichle's outstanding 
contributions to the study of human brain function using 
positron emission tomography and magnetic resonance 
imaging. Raichle, widely considered the father of cognitive 
neuroscience, and his colleagues revolutionized the study of 
brain behavior through the development and use of functional 
brain imaging techniques. 
With its membership of more than 38,000 basic scientists 
and physicians, SfN is the largest neuroscience organization 
in the world. SfN's peer-reviewed Journal of Neuroscience 
is highly regarded as one of the preeminent publications 
in the field. 
Hildebolt named AAAS 
fellow 
Charles Hildebolt, DDS, PhD, professor of radiol- 
ogy and adjunct professor of anthropology, was one 
of six Washington University faculty members elected 
to fellowship in the American Association for the 
Advancement of Science (AAAS), the world's largest 
general scientific society. 
Hildebolt is internationally known for his scien- 
tific studies of morphometric variations in the skulls, 
brains, and teeth of contemporary humans and fossil 
hominids, with particular emphasis on the brain of 
Homo floresiensis—or Hobbit, as the 18,000 year-old 
specimen is commonly known. 
AAAS is an international organization dedicated 
to advancing science, engineering, and innovation 
through education, leadership, and professional asso- 
ciation. Science, the academic journal of the AAAS, is 
one of the world's most prestigious scientific journals. 
ntur 
Welch twice honored 
For Michael Welch, PhD, professor of 
radiology, of chemistry, and of molecular 
biology and pharmacology, September 2008 
was a very good month. 
In early September, Welch received the 
2008 Distinguished Basic Scientist award 
from the Academy of Molecular Imaging 
(AMI) for his contributions to the field of 
molecular imaging. 
In late September, he was one of 
three honorees who received Washington 
University School of Medicine's Second 
Century Award. The award was initiated in 
1991—the medical school's 100-year 
anniversary— to celebrate the advent of the 
second hundred years of excellence in 
research, teaching, and patient care. 
Larry Shapiro, MD, dean and executive vice chancellor for medical affairs, presents Welch (right) with the 
Second Century Award. The symbolization of the award: flat triangular sheet—corners of the world from 
which knowledge is gathered; flame in center—knowledge expanded by researchers, clinicians, and teachers; 




Michael Darcy, MD, 
professor of radiology and 
of surgery, was elected to 
a two-year term as chair- 
man of the Society of 
Interventional Radiology 
(SIR) Foundation. The 
Foundation fosters researcl 
and the advancing clinical 
needs of interventional 
radiology, which has 
emerged as a medical 
specialty over the past 
30 years. 
John Kotyk, PhD, 
research associate profes- 
sor of radiology, was electc 
vice-chairman of the Sociel 
of Noninvasive Imaging in 
Drug Development, one of 
four councils of the Acad- 
emy of Molecular Imaging 
(AMI). As vice-chairman, 
Kotyk also serves on the 
AMI Board of Directors. 







for Children, an 
international health- 
care system, has 
been treating children-from birth to age 18-who have orthopaedic conditions burns 
spinal cord injuries, and cleft lip and palate. The Shriners Hospital in St. Louis, which first 
opened in 1924 on the Washington University Medical Center (WUMC) campus, is recognized 
throughout the Midwest as a leader in pediatric orthopaedics. 
After more than four decades at its current location on Lindbergh Boulevard in west 
«!' u°m^°     y' Shrmers HosPital has broken ground for a 147,000-square-foot facility on 
the WUMC campus, with plans for construction to begin in the fall of 2009 The hospital 
will continue to operate as a freestanding facility, but the location between Taylor and 
Newstead avenues will foster a closer collaboration with specialists at Washington 
University School of Medicine and St. Louis Children's Hospital 
Journal recognizes reviewers 
In the January 2009 issue of Radiology, Mallinckrodt 
Institute faculty were among those recognized by the journal's 
Lditonal Board for providing high quality, detailed, and 
scholarly reviews: 
• William McAlister, MD, professor of radiology and of 
pediatrics—Editor's Recognition Award with Distinction 
• Christopher Moran, MD, professor of radiology and of 
neurological surgery—Editor's Recognition Award with 
Special Distinction 
• Franz Wippold, MD, professor of radiology—Editor's 






University medical students 
present Distinguished Service 
Teaching Awards to faculty 
and house staff for their out- 
standing service in medical 
student education and the 
training of future physicians. 
Sanjeev Bhalla, MD, 
associate professor of radiol- 
ogy, was one of 10 honorees 
selected by the Class of 2009 
to receive a Clinical Teacher 
of the Year Award. 
Allyson Zazulia, MD, 
associate professor of neu- 
rology and of radiology, was 
one of 10 recipients of the 
Class of 20.10's Distinguished 
Service Teaching Award. 
WUSM facts 
• The University's medical 
department—as Washing- 
ton University School of 
Medicine (WUSM) was 
first called—was estab- 
lished in 1891. 
• Women were admitted as 
medical students in 1918. 
• 17 Nobel laureates have 
been associated with 
WUSM. 
• 14 faculty members are 
fellows of the National 
Academy of Sciences. 
• 26 faculty members belong 
to the Institute of Medicine. 
• WUSM has 1,727 faculty 
members; 6,180 staff; 789 
fellows and trainees; and 
992 house staff. 
• With nearly 1,000 
physicians, WUSM has 
one of the three largest 
academic clinical 
practices in the nation. 
• The medical school 
has 20 departments; 
Mallinckrodt Institute 
serves as the Department 
of Radiology. 
• The medical school has 
12 graduate/teaching/ 
research programs. 
• More than 4,000 students 
applied for admission 
to WUSM's 2008-2009 
first-year class; 122 
students were enrolled. 
• Currently, there are 
1,232 students enrolled 
at WUSM, with 594 of 
those students pursuing 
an MD, MD/PhD, or 
MA/MD degree. 
Excerpted from Facts 2009, 
published by Washington Uni- 
versity School of Medicine. 
Wt, 
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SCIENTIFIC ASSEMBLY 
AND ANNUAL MEETING 
OF THE 
RADIOLOGICAL SOCIETY; 
OF NORTH AMERICA 
„ur work is more interconnected 
with the rest of the world than it has 
ever been. ... If we are to ensure 
that the world turns to us as lead- 
ers in imaging, we must be viewed 
as representing the highest level of 
subspecialized patient care." 
—from the welcoming message given by 
Teresa McCloud, MD, 2008 RSNA president 
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MIR PRESENTATIONS 
AT RSNA 2008       i 
EDUCATION EXHIBITS AND 
SCIENTIFIC POSTERS 
Meghan Lubner, MD; Constantine Raptis, MD; 
Rex Parker, MD; Kathiyn Fowler, MD; Sanjeev 
Bhalla, MD; Christine Menias, MD, 
"Vasculitudes and vascular syndromes in the 
abdomen and pelvis: a pictorial review." 
—MAGNA CUM LAUDE AWARD 
Celine Buckley, MD; Christine Peterson, MD; 
Christine Menias, MD, "Teratomas from head 
to toe: a multimodality review with pathologic 
correlation."—CERTIFICATE OF MERIT 
Kristopher Cummings, MD; Fernando 
Gutierrez, MD; Sanjeev Bhalla, MD; Cylen 
Javidan-Nejad, MD, "The "outer space": 
pericardial anatomy and disease processes." 
—CERTIFICATE OF MERIT 
Cylen Javidan-Nejad, MD; Fernando 
Gutierrez, MD; Carlos Restrepo, MD; Sanjeev 
Bhalla, MD, "Nipples of the chest: aortic lumps 
and bumps."— CERTIFICATE OF MERIT 
Cylen Javidan-Nejad, MD; Fernando 
Gutierrez, MD; Andrew Bierhals, MD; Gory 
Ballester, MD; Travis Hillen, MD, "Cracking 
the chest: approaches to cardiothoracic 
surgery."—CERTIFICATE OF MERIT 
Fernando Gutierrez, MD; Andrew Bierhals, 
MD; Victor Davila, MD, "Where is the wire? 
Assessing cardiovascular pacing leads." 
Fernando Gutierrez, MD; Andrew Bierhals, 
MD; Cylen Javidan-Nejad, MD; Sanjeev, 
"Pieces of the heart: segmental analysis of con- 
genital heart disease." 
Constantine Raptis, MD; Absar Ahmed, MBBS; 
Akash Sharma, MD; Cylen Javidan-Nejad, 
MD; Thomas Watson, MD; Sanjeev Bhalla, 
MD, "Multimodality approach to the pulmonary 
nodule: a current review." 
Geetika Khanna, MD; Takashi Sato; Polly 
Ferguson, MD, "Chronic recurrent multifocal 
osteomyelitis: a pictorial review." 
Aaron Berg, MD; Yutaka Sato, MD; Geetika 
Khanna, MD; Toshio Moritani, MD, PhD; 
Resmiye Oral, MD; Patricia Kirby, MD, 
"Subdural hematomas associated with 
nonaccidental head injury: neuroimaging of 40 
nonaccidental head injury (NAHI) cases with 
subdural hematoma are reviewed and com- 
pared to age matched noninflicted head 
injuries in a university hospital setting." 
Simon Kao, MD; Geetika Khanna, MD; 
Michael D'Alessandro, MD; Yutaka Sato, MD, 
"Three-dimensional computed tomography (CT) 
in pediatric chest (excluding cardiac) diseases." 
Janice Lee, MD; David Cipolla, MD; Jesse 
Chusid, MD; Deborah Reede, MD; Sanjeev 
Bhalla, MD; Rakesh Shah, MD, "Inflammatory 
diseases of the trachea." 
Meghan Lubner, MD; Christine Menias, MD; 
Vamsi Narra, MD, "Spectrum of angiocentric 
tumors of the abdomen and pelvis with patho- 
logic correlation." 
Vincent Mellnick, MD; Constantine Raptis, 
MD; Majesh Makan; Andrew Bierhals, MD; 
Susan Holley, MD, PhD; Sanjeev Bhalla, MD, 
"You don't know JACC: describing valvular 
pathology in the language of the cardiologist." 
Nirvikar Dahiya, MD; Celine 
Buckley, MD; Christine Peterson, 
MD, "3D ultrasound imaging of 
congenital uterine anomalies in 
the age of MRI." 
Lance Reinsmith, MD; Michelle 
Miller-Thomas, MD; Franz Wip- 
pold, MD, "Blue in the face: small 
round blue cell tumors of the 
sinonasal tract." 
Anna Linda, MD; Marco Trovo, 
MD; Cylen Javidan-Nejad, MD; 
Jeffrey Bradley, MD, "Radiation 
injury of the lung after stereotactic 
body radiation therapy (SBRT) for 
lung cancers: a timeline-based 
illustration of CT findings." 
Ibrahim Saeed, MD; Sanjeev Bhalla, MD; 
Kristopher Cummings, MD; Fernando 
Gutierrez, MD; Benico Barzilai, MD; Pamela 
Woodard, MD, "Contraindications and side 
effects of commonly used medications in 
coronary CT angiography." 
Andrew Bierhals, MD; Fernando Gutierrez, 





The Radiological Society of North America has 
more than 42,000 members in 121 countries 
and 6 continents. The Society's annual scientific 
assembly is the largest international medical 
meeting in the world. 
• Approximately 60,000 attendees 
• 726 technical exhibits, occupying 516,199 
square feet 
• 1,803 scientific papers presented in 16 
subspecialties 
• 252 refresher courses and 86 multisessions 
offered 
• 1,667 education exhibits and 657 
scientific posters displayed 
Rex Parker, MD; Constantine Raptis, MD; 
Kristopher Cummings, MD; Ibrahim Saeed, 
MD; Fernando Gutierrez, MD; Sanjeev Bhalla, 
MD," Left ventricular outflow obstruction: more 
than just aortic stents." 
Constantine Raptis, MD; Sanjiv Bajaj, MD; 
Rebecca Chernock, MD; Catherine Young, 
MD, JD; Travis Henry, MD; Sanjeev Bhalla, 
MD, "Looking to the future: reviewing the 
International Association for the Study of Lung 
Cancer (IASLC) recommendations for the new 
staging of lung cancer." 
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MIR PRESENTATIONS 
AT RSNA 2008 
EDUCATION EXHIBITS AND 
SCIENTIFIC POSTERS continued 
Ibrahim Saeed, MD; Prakash Masand, MD; 
Sanjeev Bhalla, MD, "Non-atherosclerotic 
coronary artery disease: beyond sludge in the 
pipes." 
Travis Hillen, MD; Christine Menias, MD; 
Srinivasa Prasad, MD; Amy Hara, MD, 
"Carcinoid tumors: pictorial review with 
pathology correlation." 
Alexander Sevrukov, MD; Meghan Lubner, 
MD; Christine Menias, MD, "Inflammatory 
pseudotumor: the greatest mimicker." 
|RSNA| 
(Left to right) doctors Sanjeev Bhalla, Fernando 
Gutierrez, and Kristopher Cummings 
Meghan Lubner, MD; Christine Menias, MD; 
Srinivasa Prasad, MD; Kumaresan 
Sandrasegaran, MD; Perry Pickhardt, MD, 
"A pattern-based approach to retroperitoneal 
neoplasms." 
Meghan Lubner, MD; Christine Menias, MD; 
Amy Hara, MD, "The acute Gl bleeder." 
Meghan Lubner, MD; Aya Kamaya, MD; Terry 
Desser, MD; Christine Menias, MD, "The com- 
plicated fibroid: a pictorial review." 
Arpit Nagar, MBBS; Srinivasa Prasad, MD; 
Christine Menias, MD; Vijayanadh Ojili, MD; 
Venkateswar Surabhi Rao, MBBS; Kedar 
Chintapalli, MD, "Hepatobiliary and pancreatic 
autoimmune diseases: a comprehensive review 
with emphasis on cross-sectional imaging findings." 
Suleman Merchant, MD, 
from Mumbai, India, with 
MIR's Alok Jaju, MD, and 
Marilyn Siegel, MD 
Arpit Nagar, MBBS; Srinivasa Prasad, MD; 
Christine Menias, MD; Venkateswar Surabhi 
Rao, MBBS; Rajeev Suri, MD; Vijayanadh 
Ojili, MD, "Imaging spectrum of bleeding 
tumors in the belly: the usual and the not so 
usual suspects." 
FOCUS SESSIONS 
Ella Kazerooni, MD; Joel Fishman, MD, PhD; 
Paul Stein, MD; Pamela Woodard, MD; Diana 
Litmanovich, MD, "Imaging algorithms in pul- 
monary embolism: so many tests, so little time." 
David Rubin, MD; Carlo Martinoli, MD; Sherri 
Birchansky, MD, "Peripheral nerve imaging at 
the crossroads of musculoskeletal imaging and 
neuroimaging." 
Sharlene Teefey, MD, "Musculoskeletal US: 
Has the time come? Accuracy of shoulder US." 
Milton Guiberteau, MD; Michael Federle, MD; 
James Thrall, MD; Henry Royal, MD; Todd 
Blodgert, MD, "PET/CT: Who should read it?" 
INFORMATICS 
Lawrence Tarbox, PhD; Gianluca Paladini, 
BEng; Patric Ljung, PhD, "XIP™: The extensible 
Imaging Platform—a platform for rapid appli- 
cation development and deployment." 
MULTISESSION COURSES 
Pamela Woodard, MD; Vincent Ho, MD, 
"Cardiac CT mentored case review: Part I (in 
conjunction with the North American Society 
for Cardiac Imaging)." 
Geoffrey Rubin, MD; Pamela Woodard, MD, 
"Cardiac CT mentored case review: Part II (in 
conjunction with the North American Society 
for Cardiac Imaging)." 
Erik Paulson, MD; Daniel Boll, MD; William 
Small, MD, PhD; Douglas Katz, MD; Jay 
Heiken, MD, "Gastrointestinal/emergency 
series: imaging of the acute abdomen." 
Albert Nemcek, MD; William Stavropoulos, 
MD; Brian Funaki, MD; Michael Darcy, MD, 
"Case-based review of interventional radiology: 
vascular diagnosis (in conjunction with the 
Society of Interventional Radiology)." 
Marilyn Siegel, MD, "Pediatric CT angiography." 
PLENARY SESSION 
Michael Welch, PhD, "Nanotechnology in the 
future of imaging: prospects and pitfalls." 
— EUGENE P. PENDERGRASS NEW 
HORIZONS LECTURE 
REFRESHER COURSES 
Sanjeev Bhalla, MD, "State-of-the-art imaging 
for penetrating trauma thorax." 
Christine Menias, MD, "State-of-the-art imaging 
for penetrating trauma abdomen." 
Pamela Woodard, MD, "Cardiac—principles 
and techniques of cardiac CT angiography 
and MR imaging and reduction strategies: 
MR imaging." 
Lawrence Tarbox, PhD, "Integration strategies 
for radiology systems (advanced imaging 
informatics) DICOM WG23 plug-ins." 
Fernando Gutierrez, MD; Kristopher Cummings, 
MD; Sanjeev Bhalla, MD, "Multidetector CT and 
MR evaluation of congenital thoracic disease in 
the adult (noncardiac)—How-to Workshop." 
Marilyn Siegel, MD, "Practical pediatric 
vascular imaging: CT imaging." 
Christine Menias, MD, "Imaging of the 
gallbladder and bile ducts: malignant lesions 
(including gallbladder carcinoma)." 
Sanjeev Bhalla, MD, "CT angiography of 
chronic pulmonary embolism." 
William Palmer, MD; Louis Gilula, MD, 
"Musculoskeletal interventional procedures." 




•RSNA Research Medical 
Student Grant—Guillermo 
Gonzalez/'Evaluafion of hepatic 
steatosis on contrast-enhanced 
computed tomography scan." Mentors: 
Jay Heiken, MD; Kathryn Robinson, MD 
• RSNA Research Medical 
Student Grant—Ephraim Parent, 
PhD, "Directed radiotherapy of MCF-7 
cells using 16a-[77Br]-bromo-llb- 
methoxyestradiol-17b." Mentor: 
Michael Welch, PhD 
• Roentgen Resident/Fellow 
Research Award—Jonathan 
McConathy, MD, PhD 
Barry Siegel, MD, "Update course in diagnostic 
radiology: clinical PET and PET/CT imaging— 
abdominopelvic PET/CT and the Medicare PET 
Registry, The National Oncologic PET Registry." 
SCIENTIFIC SESSIONS 
Stephanie Wilson, MD; Luigi Solbiati, MD; 
Sharlene Teefey, MD, "Gastrointestinal 
(ultrasound contrast: liver)." 
Richard Smelka, MD; lhab Kamel, MD, PhD; 
Jay Heiken, MD, "Gastrointestinal (liver 
imaging: diffuse diseases)." 
Marcus Kessler, MD; Marilyn Siegel, MD, 
"Cytomegalovirus infection in pediatric lung 
transplant recipients." 
Mitchell Machtay, MD; Abass Alavi, MD; 
Suddho Acharrya, PhD; Janet Saffer, PhD; 
Bradley Snyder, MS; Barry Siegel, MD, "ISP: 
Nuclear medicine (PET/CT of the neck and 
chest)—Local institution versus central review 
determination of SUV for stage III non-small 
cell lung cancer: preliminary analysis of ACRIN 
6668/RTOG 0235." 
Barbara Monsees, MD; Constance Lehman, 
MD, "Breast imaging (interventional)." 
Cheryl Herman, MD; Mary Mahoney, MD, 
'Breast imaging (interventional)." 
/ 
"One of the most promising areas on the 
horizons of medical discovery involves the use 
of particles fifty-thousand times smaller than a 
human hair."—Michael Welch, PhD, the Eugene 
P. Pendergrass New Horizons Lecturer. 
Suresh Vedantham, MD, "ISP: vascular/inter- 
ventional (venous interventions and dialysis)." 
Mark Murphey, MD; David Rubin, MD, 
"Musculoskeletal (soft-tissue tumors: 
quantitative and qualitative assessment)." 
Erik Paulson, MD; Christine Menias, MD, 
"Gastrointestinal (acute appendicitis)." 
Anna Linda, MD; Christine Peterson, MD; 
Kathryn Robinson, MD; Michael Lin, MD; 
Guillermo Gonzalez; Jay Heiken, MD, 
"Gastrointestinal (liver focal lesions): 
atypical imaging findings of pyogenic 
hepatic abscesses." 
Lauren Anderson; William Middleton, MD; 
Sharlene Teefey, MD; Carl Reading, MD; Jill 
Longer, MD; Terry Desser, MD; Margaret 
Szabunio, MD; John Cronan, MD; Susan 
Mandel, MD, "Neuroradiology/head and 
neck (sonography/elastography): analysis of 
sonographic features and recommendations for 
management of thyroid nodules in patients with 
a family history of thyroid cancer." 
Daniel Wessell, MD, PhD, and (right) David Rubin, MD 
Carol Andrews, MD; Daniel Wessell, MD, 
PhD, "Musculoskeletal/emergency (skeletal 
trauma)." 
Alok Jaju, MD; Marilyn Siegel, MD; Keith Fis- 
cher, MD, "Functional CT scans for bronchiolitis 
obliterans syndrome: correlation with ventilation- 
perfusion scans." 
Karen Tong, MD; Colin Derdeyn, MD; Lucien 
Levy, MD, PhD, "Neuroradiologyfbrain: 
techniques—susceptibility-weighted imaging)." 
in an Informatics session, Lawrence Tarbox, PhD, 
discussed an imaging platform for rapid application 
development and deployment. 
Dmitriy Yablonskiy, PhD; James Quirk, MD, 
PhD; Barbara Lutey; Jason Woods, PhD; Alex 
Sukstanskii, PhD; David Gierada, MD, "ISP: 
Chest (COPD: emphysema and quantification)— 
in vivo lung morphometry with hyperpolarized 
3He diffusion MR identifies lung microstructure 
changes in the initial stages of emphysema." 
Pascal Sati, PhD; Anne Cross, MD; Adil Bashir, 
PhD; Dmitriy Yablonskiy, PhD, "Gradient 
Echo Plural Contrast Imaging: a novel MRI 
technique for evaluating multiple sclerosis." 
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Uncle Charles 
a new era in colorectal 
cancer screening 
by Amy Thomas, MD, FAAP ^ 
The story is familiar to mosf: 
was tired this past month. Then he had a bloody stool, 
which prompted him to see a doctor. Uncle Charles was 
diagnosed with colon cancer that had spread throughout his 
body, leaving him with less than six months to live. Wouldn't 
we all enjoy the alternative scenario in which Uncle Charles 
underwent a simple radiographic test and the cancer that 
was found was small enough to be removed later that same 
day? A new screening test called computed tomography 
colonography (CTC), or virtual colonoscopy, may increase 
the likelihood of the second scenario. 
FOCAL SPOT, WINTER 2008/2009 
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TO CATCH i CANCER: 
a new era in colorectal cancer screening 
collaboration 
with researchers 
across the country, 
physicians at 
Mallinckrodt Institute 
of Radiology at Washington 
University recently published 
the results of a landmark study 
that could overcome common 
barriers to colorectal cancer 
screening—barriers that annually 
claim nearly 700,000 lives 
worldwide. Through virtual 
colonoscopy, doctors hope to 
increase the number of people 
getting screened for colorectal 
cancer, improving survival rates 
for people with the disease. 
Detecting colorectal concer 
Though it's one of the most 
curable cancers when diagnosed 
early, the most common symptom 
of colorectal cancer (cancer of 
the colon or rectum) is no symptom 
at all, so the disease is often dis- 
covered too late for effective 
treatment. Colorectal cancer can 
grow for many years before a per- 
son has any physical indication that 
something is wrong. Once the can- 
cer spreads beyond the colon, it is 
much more difficult to treat. Until 
recently, the most effective way to 
catch colorectal cancer early was 
colonoscopy—an examination in 
which a five-foot-long, fiber-optic 
camera is inserted into the rectum 
and moved throughout the colon to 
look for suspicious growths. 
Though this test could be quite 
effective in reducing deaths from 
colorectal cancer, many people 
avoid the procedure for fear of 
having an invasive examination of 
the bowel, undergoing sedation, 
and losing a full day away from 
work or daily routines. As a result, 
less than 40 percent of people 
comply with screening recommen- 
dations, leaving colorectal cancer 
as the second leading cause of 
cancer death in the United States. 
An Alternative method 
CT colonography is a less-inva- 
sive examination to diagnose col- 
orectal cancer in its early stages, 
when treatment is simple 
and curative. The test enables doc- 
tors to visualize the inside of the 
entire colon by taking pictures 
from outside of the patient's body, 
making the test less intrusive and 
much more patient-friendly. For 
some time CTC has been recog- 
nized as an alternative colorectal 
cancer-screening test, but the 
...colorectal cancer the second leading cause 
of cancer death in the United States. 
results of past scien- 
tific investigations 
were inconclusive as 
to whether imaging 
would detect early 
cancers as well as 
colonoscopy does. 
Far Left: 2-D computed tomog- 
raphy image of an adenomatous 
polyp in the cecum 
Left: 3-D computed tomography 
image of the same adenomatous 
polyp in the cecum, as seen in 
the 2-D image 
10 MALLINCKRODT INSTITUTE OF RADIOLOGY 
In 2003, a 
groundbreaking 
study demon- 
strated that CTC 




tal cancer. These 
results, in part, led 
to the launch of 










In the fall of 2008, researchers 
released the results of this land- 
mark study: CTC is as effective as 
colonoscopy in the detection of 
early-stage colorectal cancers. The 
findings, published in the September 
18th issue (volume 359, number 12) 
of the New England Journal of 
Medicine, could be the cornerstone 
of future colorectal cancer- 
screening recommendations. 
Jay Heiken, MD, professor 
of radiology, served on the execu- 
tive committee of the National 
CT Colonography Trial. "CT 
colonography provides individuals 
with a relatively noninvasive option 
for colorectal cancer screening," he 
"CT colonography provides individuals 
with a relatively noninvasive option for 
colorectal cancer screening" 
Jay Heiken, MD, chief of the Abdominal Imaging sec- 
tion at Mallinckrodt Institute, is in a computed tomog 
raphy suite on the medical center's north campus. 
detecting colorec- 





of radiology at 
Mallinckrodt Insti- 
tute, served as the 
principal investi- 
gator at Washing- 
ton University—one of fifteen sites 
throughout the country. 
says. "At this time fewer than half 
of those recommended for screening 
are having it done, so people are 
putting themselves at risk. People 
are dying who needn't be—fatal 
cancers can be prevented by early 
detection through screening." 
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TO CRTCH n CRNCER: 
a new era in colorectal cancer screening 
I 
In the Spring 2006 Focal Spot magazine coverage of the National 
CT Colonography Trial at Mallinckrodt Institute, Ruth Holdener, RT, 
(seated) and Christine Menias, MD, reviewed images of the colon 
obtained by a 64-detector CT scanner. 
CTC 
The test is minimally 
invasive, takes about 10 to 
15 minutes, and can detect 
as many precancerous and 
cancerous growths as 
does a standard screening 
colonoscopy. 
During the procedure, 
the patient lies supine on 
a table, and a small plastic 
tube is used to pump car- 
bon dioxide through the 
rectum to distend the 
bowel. Then, the patient 
is moved on the table 
through a CT scanner 
for about 10 to 15 seconds 
while images are obtained; 
the process is repeated 
with the patient lying 
face down. 
The images taken by the CT 
scanner are transferred to a com- 
puter that generates 2-D and 3-D 
images of the colon and rectum, 
which are interpreted by an experi- 
enced radiologist. If a suspicious 
polyp is found, the patient is 
referred for a standard 
colonoscopy to have the polyp 
removed. By using CTC as the 
initial screening test, nearly 80 
percent of patients could avoid the 
more invasive procedure and its 
associated risks. 
In the past, some patients 
reported preferring colonoscopy 
because they would rather be 
sedated for the exam and that 
bowel insufflation for the CTC 
caused moderate cramping. But 
now, radiologists are using carbon 
dioxide to fill the bowel, which is 
reabsorbed quickly and is much 
National CT Cnlnnnnrantiu Trial 
Funded by the National Cancer Institute 
and coordinated by the American College of 
Radiology Imaging Network, the trial involved 
2,600 asymptomatic individuals who were 
screened at these 15 sites: 
ARIZONA 
Mayo Clinic Scottsdale 
Scottsdale Medical Imaging 
CALIFORNIA 
University of California Los Angeles Medical Center 
San Francisco VA Medical Center 
University of California San Diego Medical Center 
COLORADO 
Radiology Imaging Associates 
CONNECTICUT 
Yale University/VA Connecticut Healthcare System 
ILLINOIS 
University of Chicago Hospital 
Clinical Radiologists SC at Memorial Medical Center 
MARYLAND 
Johns Hopkins Hospital and Health Center 
MASSACHUSETTS 




Mallinckrodt Institute of Radiology, Washington 
University Medical Center 
TEXAS 
The University of Texas, MD Anderson Cancer Center 
VIRGINIA 
Medical College of Virginia Hospitals 





Use of this illustration from Wikipedia is granted under the GNU Free 
Documentation License. 
more comfortable than was the 
room-air insufflation used in the 
past. With the new technique, 
cramping is mild and has typically 
resolved by the time the patient is 
anesthesia comes with 
some risk. Sedation also 
requires that the patient 
have someone drive them 
home after the exam. With 
CTC, there is no downtime 
after the procedure and 
patients can drive them- 
selves to work or home. 
RecommendaNons and cosTs 
The American Cancer 
Society (ACS) now recom- 
mends CTC as a screening 
option for colorectal 
cancer, a decision partly 
based on the results of the 
national study. ACS recom- 
mends that people undergo 
CTC every five years start- 
ing at age 50. The cost of 
the test ranges from $500 to 
$2,000. Currently, insurance carri- 
ers or HMOs cover CTC screening 
for only a select group of patients: 
those who have had an incomplete 
or failed colonoscopy or have a 
"...decision to provide insurance coverage for 
CT colonography will encourage more people 
to participate in routine screening...." 
walking out the door—usually 
within five minutes. Because of the 
need for bowel insufflation, CTC 
carries a small risk of bowel perfo- 
ration (a small break in the bowel 
wall), but the risk is significantly 
less than the likelihood of perfora- 
tion from a colonoscopy. And while 
sedation for a colonoscopy might 
be more attractive than staying 
awake for the CT scan, even light 
contraindication to colonoscopy 
(such as dependence on blood thin- 
ners), and those with a medical 
condition making them unsuitable 
candidates for sedation. Insurance 
also is starting to cover patients 
who refuse colonoscopy for per- 
sonal reasons but are at an in- 
creased risk of colorectal cancer as 
compared to the general population. 
In June 2008, the American 
College of Radiology, the Society of 
Gastrointestinal Radiologists, and 
the Society of Computed Body 
Tomography and Magnetic Reso- 
nance sent a joint comment letter 
to the Centers for Medicare and 
Medicaid (CMS), requesting 
reimbursement for CTC providers 
and stating that sufficient data and 
clinical evidence support the 
request. In February 2009, the CMS 
will make a decision on the cover- 
age of routine CTC screening for 
the general population. "My hope is 
that the decision to provide insur- 
ance coverage for CT colonography 
will encourage more people to 
participate in routine screening 
and, as a result, many lives will be 
saved," says Heiken. ED3 
For more information 
• NCI-Results of the National CT 




• Radiology Info: CT Colonography— 
www.radiologyinfo.org/en/ 
info.cfm?PG=ct_colo 
• American Cancer Society— 
www.cancer.org 
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by Robert Lowes 
A national, multidisciplinary trial 
spotlights a promising treatment of 
deep vein thrombosis 
or nearly 50 years, physicians have prescribed 
anticoagulants for patients with deep vein thrombosis 
[DVT) to keep blood clots in their legs and groins 
from breaking loose and travelling to the lungs, where they 
can block an artery and cause death. 
Unfortunately, it s only a 
partial triumph of medicine. Anti- 
coagulants work well in preventing 
a pulmonary embolism, but not so 
well in preventing a chronic condi- 
tion in DVT patients called post- 
thrombotic syndrome, which 
leaves their legs swollen, painful, 
tired, and sometimes useless. 
Suresh Vedantham, MD, associate 
professor of radiology and of 
surgery, has witnessed their 
suffering in his clinics. 
"Patients with post-thrombotic 
syndrome [PTSJ can't live the lives 
they want to,: says Vedantham, an 
interventional radiologist. "Walking 
is a struggle. If they have small chil- 
dren, they find it hard to care for 
them or to play with them. Many 
can't hold down a job." 
For the next five years, 
Vedantham will direct 150 
researchers across the country in 
a $10 million, government-funded 
clinical trial to determine whether 
an innovative procedure for remov- 
ing those vexing clots can prevent 
PTS, and safely so. Using image- 
guided catheters, investigators 
will deliver clot-busting medicine 
directly to clots as well as assault 
them mechanically with micro-tools. 
Vedantham anticipates that the 
procedure will prove itself as a 
powerful complement to anticoagu- 
lant therapy, but regardless of the 
outcome, the trial is already off to 
a successful start. That's because 
Vedantham has reached beyond his 
specialty of interventional radiology 
—and its penchant for catheter- 
based treatments—and recruited 
DVT experts from other fields to 
participate in the study for the sake 
of scientific rigor. What this multi- 
disciplinary team shares in common 
is a passion for vanquishing a disor- 
der that causes so much misery. 
An improvement on 
compression stockings 
Vedantham is the sponsor and 
national principal investigator in a 
trial called ATTRACT (Acute 
Venous Thrombosis: Thrombus 
Removal with Adjunctive Catheter- 
Directed Thrombolysis) that will 
involve between 25 and 50 hospitals 
and almost 700 patients. Funding 
comes primarily from the National 
Heart, Lung and Blood Institute, a 
branch of the National Institutes 
of Health (NIH), with a smaller 
component from industry sponsors. 
Patient enrollment is scheduled to 
begin in February 2009 and end 
sometime in 2011. 
The size of the trial testifies to 
the enormous health threat posed 
by deep vein thrombosis, which 
Acting U.S. Surgeon General Steven 
Galson, MD, targeted in a "Call to 
Action" in September 2008. Roughly 
250,000 new cases are diagnosed 
each year, with pulmonary 
Deep Vein Thrombosis (DVT) 
Nomwl Blood Flow OMpVWn Embolus 
embolisms accounting 
for 100,000 deaths annu- 
ally. One of two DVT 
patients experience 
painful PTS, which in 
severe cases can result in 
ulcerated, infected legs. 
The number of DVT 
cases stands to increase 
in an aging nation, since 
being over age 60 is one 
risk factor. Other risk 
factors include recent 
surgery, major trauma, 
pregnancy, cancer and 
some of its treatments, 
obesity, use of birth- 
control pills, and slow 
blood flow from lack of 
movement due to medical 
illness. Even slowed blood flow 
caused by sitting during a long trip 
can cause DVT—which explains 
why DVT is also known as 
"Economy Class Syndrome." 
Blood thinners like warfarin 
and heparin usually keep a clot 
from throwing off a deadly 
embolism, but don't eliminate the 
Copyright Society o! Interventional Radiology, www.SIRweb.org 
Site of Pulmonary Embolus 
Copyright Society ol Interventional Radiology, www.SIRweb.org 
Deep      Vein      Thrombos 
clot itself, which explains why PTS 
is such a lingering scourge for 
patients and a costly burden on the 
nation's health-care system, says 
Vedantham. "PTS has been a for- 
gotten story," he says. "We've 
focused so much on preventing 
death that we haven't paid as much 
attention to preventing disability and 
restoring a patient's quality of life." 
I   s 
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Top Left: Blood clot (oval-shaped, light-colored mass) 
in the middle of the inferior vena cava in the abdomen 
.Bottom Left: Pulmonary angiogram showing a clot 
ge white mass) blocking several branches of the lung 
It's not as if physicians haven't 
attempted to tackle PTS. The sim- 
plest way to prevent or to lessen 
swelling and pain is wearing 
graduated compression stockings 
that tighten as they go down the 
leg. Their pressure can keep blood 
from pooling and clotting. However, 
PTS occurs in 25 to 50 percent of 
DVT patients despite the use of 
compression therapy and anticoag- 
ulant drugs. In addition, many 
patients find the tight-fitting 
garments to be too uncomfortable 
or inconvenient to wear on a 
daily basis. 
Instead of controlling a throm- 
bus with an anticoagulant, why not 
destroy it with the same throm- 
bolytics used to treat heart attack 
and stroke victims? It's a tantalizing 
option, but when such drugs have 
been administered systemically, 
serious bleeding occurs too fre- 
quently to warrant this therapy 
except in the direst DVT cases 
when loss of limb is likely. More- 
over, this approach requires a slow 
drip of thrombolytics over two 
days, with back and forth trips 
from the procedure lab to the ICU. 
"It's a cumbersome process and a 
strain on precious hospital 
resources," says Vedantham. 
Fortunately, interventional 
radiologists have learned how to 
decrease the incidence of bleeding 
by administering thrombolytics 
directly into the clot with a 
catheter, which allows them to 
achieve the same results with 
smaller dosages. They've gone a 
step further and incorporated 
other catheter technologies that 
mechanically tear into the clot and, 
in the process, improve drug dis- 
persion. That, in turn, permits even 
smaller drug dosages and mini- 
mizes bleeding even more. With 
one technique, an oscillating wire 
chews up the clot while it's simul- 
taneously injected with a throm- 
bolytic. With another, a catheter 
squirts a thrombolytic into the clot 
at a high enough pressure to frag- 
ment it. Once the drug has softened 
the clot in either method, the 
catheter sucks it out. 
This pharmacomechanical, 
catheter-directed thrombolysis 
(PCDT) has lowered the risk of 
major bleeding—defined as an 
episode requiring blood transfusion 
—to between four to eight percent 
in a number of studies. Plus, PCDT 
often can be performed in two or 
three hours, dramatically reducing 
hospital costs. Such progress 
convinced the American College 
of Chest Physicians in its latest 
consensus guidelines on DVT to 
suggest catheter-directed treatment, 
including PCDT, for patients with 
extensive, acute cases in the iliac 
and femoral veins, and not just 
those with extreme cases, provided 
they have a low risk of bleeding. 
Quality of life counts 
While PCDT has gained cautious 
acceptance, the community of physi- 
cians treating DVT and PTS—which 
includes internists, vascular sur- 
geons, cardiologists, hematologists, 
obstetrician-gynecologists, family 
physicians, and pulmonologists in 
addition to interventional radiolo- 
gists—have sought firmer evidence 
that this treatment is safe enough 
'Acute Venous Thrombosis: Thrombus Removal wii 
it; MALLINCKRODT INSTITUTE OF RADIOLOGY 
(Left to right) Thomas Ortel, MD, PhD, Hemostasis and Thrombosis Clink, Duke University; Anton Sidawy, MD, 
Veterans Affairs Medical Center, Washington, DC; Mark Creager, MD, Vascular Center, Brigham and Women's 
Hospital, Boston; Rear Admiral Stephen Galson, acting U.S. surgeon general; Samuel Goldhaber, MD, Venous 
Thromboembolism Research Group, Brigham and Women's Hospital, Boston; Suresh Vedantham, MD, Mallinckrodt 
Institute of Radiology. 
to warrant widespread use, says 
Vedantham. That's the rationale for 
ATTRACT, the first randomized, 
multi-site study of PCDT. It will tar- 
get patients with new cases of DVT 
in the iliac and femoral veins who 
have symptoms of pain and swelling. 
The trial will exclude patients who 
have experienced actual PTS or a 
massive pulmonary embolism, or 
who aren't safe candidates due to a 
history of stroke, for example. 
All patients will go on standard 
anticoagulant therapy and wear 
graduated compression stockings. 
Half of the patients will be assigned 
to the study's control arm and will 
only receive anticoagulant therapy; 
the other half will be treated by one 
of several PCDT methods. If any 
clot remains, proceduralists will 
reinsert catheters and try to 
remove the clot. 
Physicians will monitor patients 
for 24 months for signs of PTS using 
the Villalta PTS Scale (a clinical 
measurement for rating the severity 
of PTS symptoms). In addition, 
patients will complete a quality-of- 
life questionnaire that asks, among 
other things, if a leg 
problem limits them in 
housework or interferes 
with social activities. A 
data-coordinating center 
at McMaster University 
in Hamilton, Ontario, 
will crunch the numbers. 
One number that 
Vedantham and others 
will watch carefully is 
the risk of major bleed- 
ing with PCDT. "I'm 
guessing it will be 
between three and five 
percent," he says. "That 
would be an acceptable 
rate if we can reduce the 
risk of PTS by half. 
Three to five percent 
compares favorably to 
the risk of major bleed- 
ing with anti-coagulants, 
which is one to two percent ini- 
tially, and one percent each year 
afterwards." In addition, 
researchers will study how the 
treatment affects the occurrence of 
pulmonary embolisms and the 
recurrence of vein clotting and 
whether it's more cost effective 
than standard DVT therapy. 
Crossing specialty lines 
In seeking NIH funding for his 
study, Vedantham was well aware 
of the problem of specialty tunnel- 
vision that psychologist Abraham 
Maslow summed up in a famous 
saying: "When the only tool you 
have is a hammer, everything 
looks like a nail." In other words, 
someone views a favorite tool—in 
the case of interventional radiolo- 
iidjunctive Catheter-Directed Thrombolysis 
J 
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gists, a catheter—as a universal 
solution, often to the dismay of 
honest skeptics and funding 
agencies like the NIH. 
"To get the whole picture, you 
must go out of your way to listen to 
people from other fields," says 
Vedantham. 
He's done just that. The steer- 
ing committee for ATTRACT is 
dominated by DVT experts from 
outside the ranks of interventional 
radiology. Its chairman, for example, 
is internist Samuel Goldhaber, MD, 
(Left to right) Colleen Kilbourrte-Glynn, ATTRACT Trial 
project manager; Melissa Bellovich, ATTRACT Trial 
project coordinator;  Patty Nieters, RN, clinical 
research nurse coordinator. 
a professor of medicine at Harvard 
Medical School and chair of the 
national Venous Disease Coalition 
(with Vedantham as vice-chair and 
chair elect). And each trial site 
fields a team that's just as multidis- 
ciplinary—an emergency medicine 
physician to identify trial candidates, 
the physician who directs the vas- 
cular ultrasound labwhere DVT is 
diagnosed, a proceduralist to per- 
form PCDT, and a medical physician 
to supervise anticoagulant therapy. 
This collaborative approach is 
a winning formula, says Lawrence 
Lewis, MD, associate professor of 
emergency medicine at Washington 
University School of Medicine, who 
sits on the ATTRACT steering com- 
mittee. "The diversity will help to 
convince people that the trial isn't 
biased in favor of physicians who 
want to make a catheter-based pro- 
cedure look good," says Lewis. 
ATTRACT already enjoys credibility, 
having been endorsed by not only 
the Society of Interventional Radi- 
ology, but also by the American 
Venous Forum (composed mostly 
of vascular surgeons) and the mul- 
tidisciplinary American College of 
Phlebology (for which Vedantham 
formerly served as a board member). 
Vedantham, a member of the ^^ 
Executive Council of the Society of 
Interventional Radiology, is happy 
to prove to his colleagues that 
using catheters to attack DVT phar- 
At the Venous Disease Coalition's Second Annual 
Meeting in September 2008, Rear Admiral Stephen 
Galson, acting U.S. surgeon general, issued a Call 
to Action to prevent DVT and PE.  Details at 
www.surgeongeneral.gov/topics/deepvein. 
maceutically and mechanically can 
dramatically reduce the incidence 
of post-thrombotic syndrome, and 
let patients live the lives they want. 
The way he sees it, the ability 
to take a walk with your child is a 
good outcome. EE3 
Editor's Note: For more informa- 
tion about the ATTRACT Trial, 
call 1-800-974-CLOT (2568). 
Post-Thrombotic Syndrome 
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Center highlighted imaging research from 
"molecule to mouse to man." The event, 
sponsored by the Division of Radiological 
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Song; Debashish Pal; Sergey 
Komarov; Daniel Keesing; Joseph 
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Robert Mach, PhD; Zhude Tu, PhD; 
Jinbin Xu; Shihong Li; Lynne Jones; E. 
Griffin; Joel Perlmutter, MD; Mark 
Mintun, MD, "Radiotracers for imaging 
dopamine D3 receptors." 
Robert Mach, PhD; Zhude Tu, PhD; 
Jinbin Xu; Suwanna Vangveravong; 
Shihonf Li; Lynne Jones; Ryuji 
Higashikubo, PhD; Delphine Chen, 
MD, "[18F]ISO-1: a novel radiotracer for 
imaging cell proliferation in tumors." 
Robert Mach, PhD; Dong Zhou, PhD; 
Wenhua Chu; Zhude Tu, PhD; Justin 
Rothfuss; Chenbo Zeng, PhD; Del- 
phine Chen, MD; Carmen Dence, MS; 
Robert Gropler, MD; Michael Welch, 
PhD, "PET imaging of cellular death." 
Yvette Sheline, MD; Abraham Snyder, 
MD, PhD; Suzhi Wang; Denise Head, 
PhD; Marcus Raichle, MD; John Mor- 
ris, MD; Mark Mintun, MD, "Alzheimer's 
Disease differs in default network spontaneous 
connectivity." 
Andrei Vlassenko, MD, PhD; Dana 
Sacco; Neil Vaishnavi; Melissa Run- 
die; Lars Couture; Abraham Snyder, 
MD, PhD; Yvette Sheline, MD; Robert 
Mach, PhD; Marcus Raichle, MD; John 
Morris, MD; Mark Mintun, MD, 
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Benjamin Shannon, PhD; Abraham 
Snyder, MD, PhD; Cindy 
Lustig; Randy Buckner, PhD; 
Marcus Raichle, MD, "Brain 
functional activity predicts subse- 
quent structural atrophy in 
Alzheimer's Disease but not 
normal aging." 
Tamara Hershey, PhD; 
Meghan Campbell; Tom 
Videen, PhD; Samar Tab- 
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MD; Joel Perlmutter , MD, 
"Mapping functions of the STN 
with deep brain stimulation in PD." 
Tamara Hershey, PhD; 
Dana Perantie; Patrick 
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ture and glycemic extremes in 
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Delphine Chen, MD; Dong 
Zhou, PhD; Aviv Hagooly; Wenhua 
Chu; Phillip Herrbrich; Lynne Jones; 
Justin Rothfuss; Mark Mintun, MD; 
Michael Welch, PhD; Robert Mach, PhD, 
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analogs for imaging caspase-3 activation with 
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John Kotyk, PhD; Agus Priatna; 
Vamsi Narra, MD; Tammie Benzinger, 
MD, PhD, "New MR technology developments 
in the CCIR: a WUSM-Siemens collaboration." 
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Neil Vaishnavi; Justin Vincent; Abra- 
ham Snyder, MD, PhD; Michael Fox; 
Felice Ghilardi, MD; Giulio Tononi, 
MD; Marcus Raichle, MD, "Effect of motor 
learning on spontaneous fMRI fluctuations." 
Neil Vaishnavi; Abraham Snyder, MD. 
PhD; Felice Ghilardi, MD; Giulio 
Tononi,MD; Marcus Raichle, MD, "Learn 
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your side is numb, 
you feel confused or 
your speech is slurred. 
If you are in bed, fhe 
worsf fhing you can 
do is driff back fo 
sleep, hoping you 
will feel beffer in 
fhe morning. 
The best thing is to call "911" 
or head immediately to a primary 
stroke center, like Barnes-Jewish 
Hospital at Washington University 
Medical Center (WUMC), where a 
trained response team will quickly 
recognize that you are one of the 
750,000 Americans each year who 
have suffered a stroke. And, if your 
case warrants, the response team 
will also see that you get a life-saving 
injection of tissue plasminogen 
activator (tPA), a powerful clot- 
dissolving agent. But there's a 
catch: tPA works best if given 
quickly, within two to three hours 
after symptoms begin. 
by Candace O'Connor 
Photographs by Kimberly Kania, MIR Photography Lab 
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he tPA treatment is 
relatively underutilized 
because it is often difficult to 
get people to the hospital in 
time, it's hard to recognize a 
stroke that quickly, it's hard 
to grease all the skids to give the 
drug as fast as possible," says Colin 
Derdeyn, MD, professor of radiology, 
of neurology, and of neurological 
surgery, and director of an innova- 
tive program that studies more 
efficient and effective treatment 
for stroke patients. 
5P0TRIA5 programs 
The medical community has 
long agreed that earlier, more 
effective ways to diagnose and 
treat strokes are urgently needed. 
Experience with tPA has proven 
that the earlier the therapy, the 
more likely the patient will make a 
good recovery. Clinicians and sci- 
entists at the National Institute of 
Neurological Disorders and Stroke 
(NINDS) recognized that the best 
place to initiate studies with this 
goal in mind is at centers that 
already are proficient in treating 
strokes. And Washington Univer- 
sity School of Medicine neurologists 
and emergency medicine staff have 
one of the best "door-to-needle" 
times in the nation: only 45 minutes 
from the emergency department 
door to the start of a potentially 
lifesaving infusion of tPA. 
In July 2008, NINDS awarded 
Washington University $9 million 
over five years to establish a 
Specialized Program for Transla- 
tional Research in Acute Stroke 
(SPOTRIAS) center, one of eight 
such programs in the country. 
The other centers in the network 
are at the University of Cincinnati, 
University of Texas at Houston, 
University of California campuses 
in San Diego and Los Angeles, 
Columbia University, Massachusetts 
General Hospital/Harvard University, 
and the National Institutes of 
Health in Washington DC. 
12 patients a year within two hours 
of symptom onset. Such a response 
time is only possible if all staff 
members—from first responders to 
emergency medicine staff—have 
been well trained in diagnosing and 
treating strokes. 
Multiple MRI images of a stroke patient who received tPA treatment. 6 hrs after stroke onset (3 hrs after tPA 
was given), a region of the brain has reperfused (red arrow), resulting in a smaller final stroke. Note that even 
the earliest OMI lesion (at 3 hrs) predicts the final stroke remarkably well. 
Nationally, the SPOTRIAS 
program began five years ago when 
the NINDS decided to support, as it 
said, "a collaboration of clinical 
researchers from different special- 
ties whose collective efforts will 
lead to new approaches to early 
diagnosis and treatment of acute 
stroke patients." To receive a 
SPOTRIAS grant, an institution had 
to prove that it had treated at least 
In 2007, the Washington Uni- 
versity/Barnes-Jewish Hospital 
team treated 45 stroke patients, 
including 20 who were treated in 
two hours or less. These patients 
come in from the immediate area 
and from more distant community 
hospitals that routinely transfer 
suspected stroke patients for 
advanced monitoring and treatment. 
Once the patients arrive, says 
Derdeyn, treating them is a "big, 
big team effort. Everyone is very 
motivated for a successful outcome." 




Response to STROKE! 
SYMPTOMSL 
The WUMC edge 
This excellence in the treatment 
of patients with acute stroke only 
allowed Washington University to 
apply for a SPOTRIAS center grant. 
Grant funding depended on the 
scientific merit of the projects 
proposed in the application. Wash- 
ington University was chosen to 
join this elite group in large part 
because of its extraordinary neu- 
roimaging capability and its track 
record in research, explained Scott 
Janis, NINDS SPOTRIAS program 
officer, on a recent site visit to 
St. Louis. "Since we are providing 
funds for infrastructure, we were 
looking for more than that," he 
said. "We are funding centers that 
are top-rated in science. It was 
science that got you [Washington 
University] in the door." 
One of the key WUMC facilities 
for the SPOTRIAS projects is 
Mallinckrodt Institute of Radiology's 
(MIR's) Center for Clinical Imaging 
Research (CCIR), led by Mark 
Mintun, MD, professor of radiology 
and of psychiatry. This research- 
dedicated, comprehensive imaging 
center is the only one of its kind in 
the nation and, possibly, the world. 
The CCIR is an innovative, biomed- 
ical imaging environment that links 
basic science and discovery efforts 
to clinical practice. The magnetic 
resonance (MR) imaging for 
patients enrolled in two of the 
SPOTRIAS projects will be per- 
formed using the CCIR scanners. 
Another is Barnes-Jewish 
Hospital's nationally recognized 
neurology-neurosurgery intensive 
care unit (NNICU), headed by 
Michael Diringer, MD, professor of 
neurology. More than 1,700 
patients are admitted annually to 
the 20-bed NNICU. The facility is 
the only neurological intensive care 
(Left to right) Jill Newgent, clinical research specialist; Abdullah Nassief, MD; Colin Derdeyn, MD; and Jennifer 
Williams, RN, are in a trauma critical care room, where stroke patients are brought for immediate evaluation. 
unit in the United States with its 
own on-site positron emission 
tomography (PET) scanner, which 
is used to measure brain blood 
flow and metabolism. 
"Big projects like SPOTRIAS 
are possible at only a few places," 
says Derdeyn. "The marriage of a 
big, private, full-service hospital 
like Barnes-Jewish with a huge 
research institution like Washing- 
ton University School of Medicine 
gives us a rare opportunity. There 
are really very few places that have 
the resources for doing these kinds 
of projects." 
Studying new approaches 
Under Derdeyn's overall 
direction, Washington University's 
SPOTRIAS team has embarked 
upon three projects: 
• STUDY 1: Focuses on the effec- 
tiveness of cholesterol-lowering 
statin agents in reducing the 
impact of vasospam after 
aneurysm rupture. This aftereffect, 
which occurs seven to 10 days 
after the rupture, causes blood 
vessels to constrict dangerously. 
For those who survive the initial 
stroke, which is caused by a rup- 
tured aneurysm, vasospasms are 
one of the major causes of death or 
long-term disability. In this pilot 
study, physicians will measure 
blood flow in the brains of 50 
stroke patients, randomly assigned 
to receive either statin or placebo 
therapy. To do this measurement, 
physicians will use the PET scan- 
ner in the NNICU. 
• STUDY 2: Targets new ways 
to determine what brain tissue 
survives after stroke. Right now, 
MR imaging is often used to 
measure blood flow, as a way to 
see what tissue is still salvageable. 
But studies in Europe have 
recently shown that MR mea- 
surements of perfusion are not 
necessarily an accurate predictor 
of outcome. 
"There are definitely patients— 
although they have received tPA 
within the first hour of their 
stroke—for whom nothing is going 
to help," says Derdeyn, who is also 
program director of MIR's endovas- 
cular surgical neuroradiology 
service. "And there are definitely 
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people who, at even six hours fol- 
lowing stroke onset, axe probably 
going to benefit from opening the 
blood vessel with tPA. Right now, 
we don't have a way to definitively 
make that prediction." 
So, physicians are testing a 
new method of measuring brain 
oxygen use with MR scanning as a 
better predictor of whether or not 
brain tissue will survive when 
reperfused. MR scans are taken 
of patients at 3.5 hours, six hours, 
and three months after a stroke to 
assess reperfusion and tissue out- 
come. So far, they have tested 
more than 20 patients and acquired 
some exciting preliminary data. 
"This could be explosively important," 
says Derdeyn. "It could really 
change the whole field. If we can 
reliably say that 'Below this level, 
you are irreversibly injured; above 
it, the tissue has good potential,' 
then the next step is to treat 
patients—even those who are six, 
eight, or twelve hours out from their 
stroke—and see how they do." 
• STUDY 3: Focuses on the cere- 
bellum or brain stem, where 10 
to 20 percent of ischemic strokes 
occur.   Some evidence indicates 
that this area may have greater 
tolerance for low blood flow 
than do other parts of the brain, 
especially the cortex, so that tPA 
may have a beneficial effect well 
outside of the normal window of 
opportunity. In this study, the 
investigative team will randomly 
assign 60 patients, all of whom 
have had cerebellar strokes more 
than three hours earlier, into 
control groups or tPA-treatment 
groups. In follow-up MR studies, 
(Left to right) Andrio Ford, MD; Katie Vo, MD; and Jin-Moo Lee, MD, PhD, are in the control room for the 3Tesla 
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Along wifh fhe work of fhe shjdy 
parficipanfs, fhe work of six "cores" 
is also crucial fo SPOTRIAS. 
• Career Development Core: headed by Mark Goldberg, MD, 
professor of neurology, of neurobiology, and of biomedical 
engineering; director of the Hope Center for Neurological 
Disorders. Is training Andria Ford, MD, a neurology fellow, 
in stroke research. One-year research fellowships are avail- 
able to residents who have completed training in radiology, 
neurology, neurological surgery, or emergency medicine. 
• Biospecimen Core: led by Mark Watson, MD, PhD, associate 
professor of pathology and immunology. Will store genomic 
and protenomic samples collected from patients enrolled in 
the three projects. This information will be linked to bio- 
informatic and imaging archives for future analysis, as well 
as shared across the network. 
• Administrative Core: headed by Colin Derdeyn, MD, profes- 
sor of radiology, of neurology, and of neurological surgery; 
with support from Robert Grubb, Jr., MD, professor of neuro- 
logical surgery. Acts as internal safety monitor. 
• Internal Advisory Committee: with Ralph Dacey, MD, profes- 
sor of neurological surgery and head of the Department of 
Neurological Surgery; Marcus Raichle, MD, professor of radi- 
ology, of neurology, and of neurobiology; John Morris, MD, 
professor of neurology and of pathology and immunology, • 
and director of the Alzheimer's Disease Research Center; 
and Lawrence Lewis, MD, associate professor of emergency 
medicine and of medicine. Will advise the Administrative Core. 
• Patient Access Core: headed by Abdullah Nassief, MD, asso- 
ciate professor of neurology; director, Clinical Stroke Cen- 
ter, and David Tan, MD, assistant professor of emergency 
medicine. Will support patient recruitment into the studies 
and the collection of biospecimens and clinical outcome 
information. 
• Imaging and Biostatical Cores: Will offer needed support. 
physicians will look for signs of the 
drug's efficacy up to three months 
later; they will also measure drug 
safety by examining its risk of 
causing bleeding as an adverse 
effect. Since brainstem strokes 
often produce more subtle symp- 
toms than do other kinds, the 
physicians hope to develop better 
ways of recognizing them. 
Looking fo fhe furure 
With the staffing provided by 
SPOTRIAS' funds—especially a 
new group of stroke-research nurse 
coordinators—Washington Univer- 
sity physicians will be able to take 
on still more projects as time goes 
on. "The core infrastructure 
provided by the SPOTRIAS grant 
has already allowed us to take on 
several other clinical trials of acute 
intervention for patients with 
strokes," says Derdeyn. "We 
now have a critical mass of stroke- 
research nurse coordinators 
to provide twenty-four/seven 
coverage for clinical trials." As 
other SPOTRIAS centers develop 
promising projects, Washington 
University physicians will be able 
to participate in those trials, 
creating a multicenter approach. 
Though the grant has a five- 
year timeline, Derdeyn and his 
colleagues hope to complete their 
work even more quickly. "The 
sooner we get all the information 
analyzed, the better able we are to 
move on to the next question, and 
that's what we would like to do," 
says Derdeyn. "We are committed 
to completing these three projects 
and getting answers, but we're 
equally committed to being in 
position in five years for the next 
five years." EM 
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can vary greatly, 
depending on 
which portion of 
the brain is affected 
and the extent of 
the damage. TBI 
affects approxi- 
mately 2 million 
people in the United 
States each year 
and is a major cause 
of death and disabil- 
ity worldwide. The 
use of improvised 
explosive devices 
(IEDs) by terrorists 
and insurgents is 
causing an alarming 
increase in blast- 
related brain injuries 
suffered by military 
men and women as well 
as by civilians. 
On October 1, 2008, 
experts involved in the 
study and treatment of 
blast-related brain injury 
met in St. Louis to discuss 
their clinical and research 
experiences. The work- 
Applications 
The Planning Committee: (standing, left to right) Gilbert Jost, MD; John Povlishock, PhD; 
Sylvain Cardin, PhD; Joseph Pancrazio, PhD; Murray Raskind, MD: Kenneth Wong, PhD; Mark 
Mintun, MD. (seated, left to right) Jean Wrathall, PhD; David Hovda, PhD; Seong Ki Mun, PhD; 
Kenneth Curley, MD 
shop—"Blast-related brain 
injury: imaging for clinical 
and research applica- 
tions"—was hosted by 
Mallinckrodt Institute. 
The meeting provided an 
opportunity for participants 
to explore current knowl- 
edge about TBI, to identify 
those areas relating to 
blast-related brain injury 
in which clinicians and 
researchers need more 
information, and to 
discuss the use of new 
imaging techniques 
to improve prevention, 
diagnosis, and treatment 
of TBI. 
Resting state fcMRI networks resemble 
task activation and anatomical networks 
Maurizio Corbetta, MD, presented "Functional connectivity 
by MRI: a physiological assay of brain function and new 
imaging modalities." 
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Army Research and Materiel Com- 
mand; Uniformed Services University 
of the Health Sciences 
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David Hovda, PhD, 
UCLA Brain Injury Research Center, 
University of California, Los Angeles 
Gilbert Jost, MD, 
Mallinckrodt Institute of Radiology, 
Washington University in St. Louis 
Deborah Little, PhD, 
Center for Stroke Research and 
Center for Cognitive Medicine, Uni- 
versity of Illinois College of Medicine 
Richard McCarron, PhD, 
Naval Medical Research Center 
Christian Macedonia, MD, 
LTC(P), MC, USA 
medical science advisor to the 
Chairman of the Joint Chiefs of Staff 
Mark Mintun, MD, 
Mallinckrodt Institute of Radiology, 
Washington University in St. Louis 
David Moore, MD, PhD, 
Defense and Veteran's Brain Injury 
Center; Defense Center of Excellence 
for Psychological Health and 
Traumatic Brain Injury 
Pratik Mukherjee, MD, PhD, 
University of California, San Francisco 
Seong-Ki Mun, PhD, 
Virginia Polytechnic Institute and 
State University 
John Povlishock, PhD, 
Commonwealth Center for the Study 
of Brain Injury 
Murray Raskind, MD, 
Alzheimer's Disease Research 
Center, University of Washington; 
Mental Illness Research, Education 
and Clinical Center, VA Puget Sound 
Health Care System 
David Ritzel, 
Dyn-FX Consulting Ltd. 
James Smirniotopoulos, MD, 
Uniformed Services University of the 
Health Sciences 
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NEW FACULTY 
Nirvikar Dahiya, MD, 
assistant professor of 
radiology, Division of 
Diagnostic Radiology. 
Suzanne Lapi, PhD, 
assistant professor 
of radiology, Division of 
Radiological Sciences. 
Hyeran Lee, PhD, instruc- 
tor in radiology, Division 
of Radiological Sciences. 
James Woods, PhD, 
assistant professor 
of radiology, Division of 
Radiological Sciences. 
GRANTS  
Tammie Benzinger, MD, 
PhD, assistant professor of 
radiology, as principal inves- 
tigator, received a one-year 
American Cancer Society 
Institutional Research Grant 
to study "Quantitative 
advanced MR imaging to pre- 
dict brain tumor response to 
stereotactic radiosurgery." 
Co investigators for the 
$30,000 grant are Joel Gar- 
bow, PhD, research associ- 
ate professor of radiology; 
Sarah Jost, MD, Swedish 
Neuroscience Institute, 
Seattle, Washington; Gerald 
Linette, MD, PhD, Depart- 
ment of Internal Medicine; 
Daniel Marcus, MD, PhD, 
research assistant professor 
of radiology; Keith Rich, MD, 
Department of Neuro- 
surgery; Joseph Simpson, 
MD, PhD, Department of 
Radiation Oncology; and 
Dmitriy Yablonski, PhD, 
professor of radiology and 
adjunct professor of physics. 
Richard Laforest, PhD, 
associate professor of radiol- 
ogy, received a one-year 
grant in the amount of 
$988,523 from the National 
Center for Research 
Resources, National Insti- 
tutes of Health, for "Acquisi- 
tion of the Inveon small 
animal PET/CT system." 
Yoram Rudy, PhD, profes- 
sor of biomedical engineering, 
cell biology, and physiology, 
of medicine, and of pedi- 
atrics, and research profes- 
sor of radiology, received a 
five-year grant of $271,356 
from Fondation Leducq in 
Paris, France, to study 
"Alliance for CaMK2 signal- 
ing in heart disease." 
Yuan-Chuan Tai, PhD, 
assistant professor of radiol- 
ogy, as principal investiga- 
tor, received a $703,000 
grant from the United States 
Department of Energy to 
study "Detector technologies 
for sub-500 micron high-sen- 
sitivity PET imaging via a 
novel PET insert approach." 
Coinvestigators for the two- 
year grant are Henric Kraw- 
czynski, PhD, Department of 
Physics, and Ling-Jian Meng, 
PhD, University of Illinois at 
Urbana-Champaign. 
Lawrence Tarbox, PhD, 
research assistant professor 
of radiology, received a 
$45,000 one-year subcontract 
with Siemens Corporate 
Research for the "Algorithm 
validation toolkit," a project 
funded by the National Cancer 
Institute's caBIG™ program. 
APPOINTMENTS/ 
ELECTIONS 
Geetika Khanna, MD, 
assistant professor of radiol- 
ogy, was appointed to the 
Institutional Participants' 
Committee of the American 
College of Radiology Imag- 
ing Network.      .  t 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, of physical ther- 
apy, and of occupational 
therapy, was appointed to 
the Advisory Board of the 
Bander Center for Business 
Medical Ethics at Saint 
Louis University. 
Scott Lecture 
On October 22, Gary Becker, executive 
of the American Board of Radiology, 
presented the Thirty-seventh Annual 
Wendell G. Scott Memorial Lecture. He 
spoke on "Quality tsunami in American 
medicine: the role of board certifica- 
tion and maintenance of certification." 
Gilbert Jost, director of Mallinckrodt Institute, pre- 
sented Becker (right) with a commemorative plaque. 
Pamela Woodard, MD, 
associate professor of radiol- 
ogy, was appointed by the 
American Heart Association 
as vice chair of the Cardio- 
vascular Radiology and 
Intervention Committee. She 
was appointed by the Ameri- 
can College of Radiology 
(ACR) as chair of the ACR 
Appropriateness Criteria, 
Cardiac Imaging Committee. 
Lawrence Tarbox, PhD, 
research assistant professor 
of radiology, was elected 
chair of the Organizing 
Committee for the 2010 
International Digital Imaging 
'. and Communications in 
Medicine Conference and 
Workshop. 
HONORS/AWARDS 
Louis Gilula, MD, professor 
of radiology, of orthopaedic 
surgery, and of plastic and 
reconstructive surgery, 
organized the 24"' Interna- 
tional Wrist Investigators 
Workshop, Chicago, Illinois. 
September 17. 





MD, PhD, professor of 
radiology and of molecular 
biology and pharmacology, 
received the 2008 Distin- 
guished Alumni Award from 
Duke University School 
of Medicine. 
Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine, and Marilyn Siegel, 
MD, professor of radiology 
and of pediatrics, received 
the Friend of the FMRI 
(Amigo de la Federation 
Mexicana) award from the 
Mexican Federation of Radi- 
ology and Imaging. The 
award was presented in a 
special ceremony at the 23rd 
National Congress of Diag- 
nostic Imaging and Therapy, 
October 29-November 1, 
Guadalajara. 
Jeffrey Zacks, MD, associ- 
ate professor of psychology 
and of radiology, received 
the F.J. McGuigan Young 




Carolyn Anderson, PhD, 
professor of radiology, of 
molecular biology and phar- 
macology, of chemistry, and 
of biochemistry, presented 
"Copper-64-labeled biomole- 
cules for molecular imaging 
! of cancer metastasis" to the 
Department of Chemistry, 
Washington State University, 
Pullman, September 29. She 
presented "Noninvasive 
imaging of osteoclasts in 
osteolytic bone metastases" 
to the Department of 
Radiology, University of 
Pennsylvania, Philadelphia, 
I October 29. 
Colin Derdeyn, MD, pro- 
fessor of radiology and of 
neurology and neurological 
surgery, spoke on "Acute 
stroke intervention: new dis- 
ease" at VIVA™ (Vascular 
InterVentional Advances) 
2008, Las Vegas, Nevada, 
September 24. He spoke on 
"Endovascular neurointer- 
vention" at the Comprehen- 
sive Brain Anatomy and 
Neurological Assessment 
Course, St. Louis, Missouri, 
October 9. 
Igor Efimov, PhD, profes- 
sor of biomedical engineer- 
ing and of radiology, 
presented "3D structure of 
the AVJ. Permanent ventric- 
ular pacing within the AVJ— 
possible new perspective 
treatment of bradysystolic 
AF" at Aritmija-Lietuva 2008, 
the 9th Biannual International 
Symposium. Klaipeda, 
Lithuania, September 19. He 
presented, via videoconfer- 
ence, "Basic aspects of nodal 
arrhythmias" to the Bakulev 
Scientific Centre for Cardio- 
vascular Surgery, the Russ- 
ian Academy of Medical 
Sciences, Moscow, October 
6. He spoke on "Pathogene- 
sis of ventricular arrhyth- 
mias in dilated cardio- 
myopathy: insights from 
optical mapping studies" at 
the 3rd Annual International 
Symposium on Ventricular 
Arrhythmias: Pathophysiol- 
ogy and Therapy, Miami, 
Florida, October 24. Efimov 
spoke on "Functional 
anatomy of the AV node: 
from rabbit to human" at the 
Cardiac Electrophysiology 
Society, New Orleans, 
Louisiana, November 8. He 
spoke on "Cardiac protec- 
tion in hibernating ground 
squirrels: the role of connex- 
ins and cadherens" at the 
University of Missouri, 
Springfield, November 21. 
He presented "Human pace- 
making and conduction sys- 
tem: from reductionism to 
integration," as part of the 
Nora Eccles Treadwell Dis- 
tinguished Lecture Series, at 
the Nora Eccles Harrison 
Cardiovascular Research 
and Training Institute, Uni- 
versity of Utah, Salt Lake 
City, December 4. 
Louis Gilula, MD, profes- 
sor of radiology, of 
orthopaedic surgery, and of 
plastic and reconstructive 
surgery, as visiting profes- 
sor, spoke on "Overview of 
musculoskeletal trauma— 
Part 1: upper extremity. Part 
2: lower extremity" at the 
Oregon Health and Science 
University, Portland, 
September 4. 
Bennett Greenspan, MD, 
instructor in radiology, 
presented "Read with the 
experts" at the annual 
meeting of the Missouri 
Valley Chapter of the Society 
of Nuclear Medicine, Omaha, 
Nebraska, October 5. 
Thomas Hermann, MD, 
associate professor of radiol- 
ogy, spoke (in Ukrainian) on 
"Embryonal tumors of child- 
hood" and "Imaging of the 
mediastinum in children, 
role of CT and MRU at the 
Conference of the Ukrainian 
Society of Radiology and the 
Danylo Halytsky LViv State 
Medical University, partici- 
pants in the 8th Scientific 
Congress of the World Fed- 
eration of Ukrainian Medical 
Associations, L'viv, Ukraine, 
August 13-17. 
Geetika Khanna, MD, 
assistant professor of radiol- 
ogy, spoke on "Imaging of 
CRMO" at the CRMO/ 
SAPHO and Behget's Confer- 
ence, sponsored by the 
National Institute of Arthritis 
and Musculoskeletal and 
Skin Diseases, National Insti- 
tutes of Health, Bethesda, 
Maryland, September 3. 
John Kotyk, PhD, research 
associate professor of radiol- 
ogy, presented "Transla- 
tional imaging research in 
the CCIR at WUSM" and 
"The development of the 
Center for Clinical Imaging 
Research at WUSM" at the H. 
Lee Moffitt Cancer Center 
and Research Institute, 
Tampa, Florida, December 
12 and 18, respectively. 
Robert McKinstry, MD, 
PhD, associate professor of 
radiology and of pediatrics, 
presented "MRI in term 
infants—interpretation" at 
the second Newborn Brain 
Symposium, sponsored by 
the Department of Pediatrics 
and St. Louis Children's Hos- 
pital, St, Louis, Missouri, 
September 10 and 11. 
Joel Perlmutter, MD, pro- 
fessor of neurology, of radi- 
ology, of physical therapy, 
and of occupational therapy, 
spoke on "Diagnostic testing 
in PD: Is it useful?" at the 
Course on De Novo Parkin- 
son Disease: Diagnosis and 
Treatment, Movement Disor- 
der Society, San Francisco, 
California, September 13. 
He presented "Dystonia: 
symptoms and pathophysiol- 
ogy" at the St. Louis Commu- 
nity Educational Forum, 
sponsored by the Dystonia 
Medical Research Forum, 
St. Louis, Missouri, 
September 28. 
Marcus Raichle, MD, 
professor of radiology, of 
neurology, of neurobiology, 
of psychology, and of bio- 
medical engineering, as 
keynote speaker, presented 
the Klaus Hofmann Lecture, 
"Two views of brain function," 
at Science 2008, sponsored 
by the University of 
Pittsburgh, Pennsylvania, 
October 2 and 3. 
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Yoram Rudy, PhD, professor 
of biomedical engineering, 
cell biology, and physiology, 
of medicine, and of pediatrics, 
and research professor of 
radiology, as the Hein Wellens 
Distinguished Professor in 
Cardiology, presented the 
keynote lecture "Computa- 
tional biology and ECG 
imaging in the study of car- 
diac electrophysiology and 
arrhythmia" at Maastricht 
University, The Netherlands, 
September 15. He spoke on 
"How to understand and 
model structure-function 
relations of ion channels?" 
and "Basic principles of ECG 
imaging from the viewpoint 
of computational modeling" 
at the Workshop on Fron- 
tiers in Computational Elec- 
trocardiology, sponsored by 
Maastricht University, The 
Netherlands, September 17. 
Rudy presented "Relating the 
action potential to the ECG" 
at the Cardiovascular System 
Dynamics Society XVIII Con- 
ference, St. Louis, Missouri, 
September 28. He presented 
"Noninvasive electrocardio- 
graphic imaging (ECGI) of 
Melson Lecture 
John Pellerito, MD, chief of ultrasound, 
computed tomography, and magnetic 
resonance imaging and director of the 
Peripheral Vascular Laboratory at 
North Shore University Hospital in 
New York, was guest speaker for the 
Sixteenth Annual G. Leland Melson 
Visiting Professorship and Lecture on 
September 24. He presented "Update 
on ectopic pregnancy." 
Pellerito (left) is shown with William Middleton, MD, 
professor of radiology. 
cardiac arrhythmia" to the 
Cardiac Rhythm Manage- 
ment Lab, University of 
Alabama, Birmingham, 
December 4. 
Nasir Siddiqi, MD, assis- 
tant professor of radiology, 
spoke on "Interventional 
radiology approach to 
hepatic brachytherapy" and 
conducted an hepatic 
brachytherapy practical 
workshop at the 4th Annual 
Brachytherapy Review, 
sponsored by the Depart- 
ment of Radiation Oncology, 
Brigham and Women's Hos- 
pital, Boston, Massachusetts, 
September 12 and 13. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
presented "PET and 
PET/CT—artifacts and vari- 
ants," "PET in oncology- 
diagnosis and staging I," 
"PET in oncology—diagnosis 
and staging II," "Gynecol- 
ogy—PET in gynecological 
cancer," "PET in oncology— 
monitoring and predicting 
response to treatment," and 
"PET/CT in breast cancer" at 
the 24"' Inter-American 
Brazilian Congress of Radiol- 
ogy/37th Brazilian Congress 
of Radiology, Belo Hori- 
zonte, October 9-11. He 
spoke on "PET and PET/CT: 
basic principles, variants and 
artifacts" and "Clinical appli- 
cations of PET and PET/CT 
in oncology" at the 23td 
National Congress of Diag- 
nostic and Therapeutic Imag- 
ing, sponsored by the Mexican 
Federation of Radiology and 
Imaging, Guadalajara, Octo- 
ber 29-November 1. 
Marilyn Siegel, MD, profes- 
sor of radiology and of pedi- 
atrics, spoke on "CT 
congenital lung lesions," 
"Pediatric renal masses," 
"CT congenital mediastinal 
vascular anomalies," "CT 
adult congenital heart dis- 
ease," "Ultrasound neonatal 
spine," and "Ultrasound 
neonatal hydronephrosis" at 
the 24th Inter-American 
Brazilian Congress of Radiol- 
ogy/S?* Brazilian Congress 
of Radiology, Belo Hori- 
zonte, October 9-11. She pre- 
sented "CT and ED imaging 
in children: techniques and 
application," "CTA and 3D 
imaging of thoracic arterial 
anomalies," and "CTA and 
3D imaging of thoracic 
venous anomalies" at CT 
Angiography and 3D Imag- 
ing: Current State of the Art, 
sponsored by Johns Hopkins 
University, Baltimore, Mary- 
land, October 17-19. She 
spoke on ""Congenital pul- 
monary lesions," "CT/MR 
pediatric hepatic masses," 
"CT/MR mediastinal 
masses," "CTA thoracic vas- 
cular lesions," and "CT/MR 
pediatric pelvic masses" at 
the 23rd National Congress of 
Diagnostic and Therapeutic 
Imaging, sponsored by the 
Mexican Federation of 
Radiology and Imaging, 
Guadalajara, October 29- 
November 1. 
Lawrence Tarbox, PhD, 
research assistant professor 
of radiology, presented "The 
evolution of DICOM—past, 
present, future" at the Joint 
Conference on Medical 
Informatics in Taiwan 2008. 
Taipei, November 22. 
Michael Welch, PhD, pro- 
fessor of radiology, of chem- 
istry, and of molecular 
biology and pharmacology, 
presented the keynote lec- 
ture "New radiopharmaceuii- 
cals for PET: current status 
and challenges" at the 48th 
Annual Scientific Meeting ( 
the Japanese Society of 
Nuclear Medicine, Chibi, 
Japan, October 24-26. 
Jeffrey Zacks, PhD, assis 
tant professor of psycholoj 
and of radiology, presentee 
"Event perception and mei 
ory: a mind-brain perspec- 
tive" at Johns Hopkins 
University, Baltimore, 
Maryland, September 25. nucl 
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SOCIETY FOR MOLECULAR 
IMAGING 
World Molecular Imaging 
Congress 
Nice, France 
September 10-13, 2008 
Grainne Biddlecombe, 
MS; William Spees, PhD; 
Joel Garbow, PhD, "Imag- 
ing extracellular pH in 
prostate tumor with Cu-64- 
DOTA-pHLIP: correlation 
between PET-CT, MRS and 
acute biodistribution." 
Delphine Chen, MD; Dong 
Zhpou, PhD; Wenhua Chu, 
PhD; Phillip Herrbrich; 
Lynne Jones; Justin Roth- 
fuss; Mark Mintun, MD; 
Michael Welch, PhD; 
Robert Mach, PhD, "In vivo 
evaluation of radiolabeled 
isatin analogs for imaging 
caspase-3 activator with 
positron emission tomography." 
Barry Edwards, PhD; 
Walter Akers, DVM, PhD; 
Philip Cheney; Yunpeng 
Ye, PhD; Richard Laforest, 
PhD; Samuel Achilefu, 
PhD, "Monitoring receptor 
targeted tumor therapy 
with a multi-modal 
imaging agent." 
Barry Edwards, PhD; 
Walter Akers, DVM, PhD; 
Samuel Achilefu, PhD; 
Buck Rogers, PhD, "Evalu- 
ation of an adenoviral vector 
encoding a SSTR2:EGFP 
chimera using optical and 
nuclear imaging." 
Riccardo Ferdani; Carolyn 
Anderson, PhD, "Compari- 
son of [MCu]Cu-LLP2A-DOTA 
and [MCu]Cu-LLP2A-CB- 
TE2A as conjugates for in 
vivo imaging of ou|3i integrin." 
Riccardo Ferdani; Carolyn 
Anderson, PhD, "Targeted 
molecular imaging of inte- 
grin 0^6 with MCu- and I8F- 
labeled peptide tracers." 
Kelly Flentie; David 
Piwnica-Worms, MD, PhD, 
"Non-destructive, biolumi- 
nescence monitoring of sal- 
monella invasion of 
eukaryotic cells." 
Joel Garbow, PhD; Joseph 
Ackerman, PhD, "Hydro- 
chalarones: a novel endohe- 
dral metallofullerene 
platform for the develop- 
ment of targeted MRI 
contrast agents." 
Scott Harpstrite, MS; 
Julie Prior; David 
Piwnica-Worms, MD, PhD; 
Vijay Sharma, PhD, "Pre- 
clinical development of a 
67Mefc
-radiopharmaceutical 
for monitoring MDR1 P-gly- 
coprotein-mediated trans- 
port at the blood-brain 
barrier (BBB)." 
Ralph Nothdurft, MS; 
Walter Akers, DVM, PhD; 
Joseph Culver, PhD; 
Samuel Achilefu, PhD, 
"High precision fluorescence 
lifetime tomography of a 
targeted optical probe in a 
living mouse." 
David Piwnica-Worms, 
MD, PhD, "Real-time biolu- 
minescence imaging of lig- 
and-induced lkp„ signal 
transduction in live cells"; 
"Optical in vitro molecular 
imaging assays": "Molecular 
imaging captures the highs 
and lows of endogenous 
Cdc25A in mice and MEFs." 
Kooresh Shoghi, PhD; 
Joel Garbow, PhD; Zhude 
Tu, PhD; Robert Mach, 
PhD, "Multi-modality evalua- 
tion of sigma-2 ligand 
radiopharmaceutical as a 
predictive marker of tumor 
proliferation with response 
to therapy." 
Thaddeus Wadas, PhD; 
Alexander Zheleznyak; 
Christopher Sherman; 
Riccardo Ferdani; Kexian 
Liang; Samuel Achilefu, 
PhD; Carolyn Anderson, 
PhD, "Preparation and bio- 
logical evaluation of "Cu-CB- 
TE2A-sst>ANT, a somato- 
statin antagonist for PET 
imaging of somatostatin 
receptor positive tumors." 
Michael Welch, PhD, "Dual- 
modality nanoparticles for 
PET/MR imaging in vivo." 
Mai Xu, PhD; Samuel 
Achilefu, PhD, "Monoclonal 
antibody CC188 binds carbo- 
hydrate epitope expressed 
on the surface of both col- 
orectal cancer stem cells and 
their differentiated progeny." 
Yunpeng Pe, PhD; Samuel 
Achilefu, PhD, "Efficient 
transformation of dicar- 
boxylic acid-containing car- 
bocyanine dyes into their 
mono-acid analogs." 
Yunpeng Ye, PhD; Bao- 
gang Xu; Samuel Achilefu, 
PhD, "Novel chimerical fluo- 
rescent probes for optical 
imaging of amyloid |3-peptide 
aggregates." 
Alexander Zheleznyak; 
Thaddeus Wadas, PhD; 
Julie Prior; Lynne Collins; 
David Piwnica-Worms, 
MD, PhD; Carolyn Ander- 
son, PhD, "Imaging o^Pg in 





2008 Nuclear Science 
Symposium and Medical 
Imaging Conference 
Dresden, Germany 
October 19-25, 2008 
Sergey Komarov, PhD; 
Heyu Wu, PhD; Tae Song, 
PhD; Joseph O'Sullivan, 
PhD; Yuan-Chuan Tai, 
PhD, "Characterization of 
the Compton scattering in 
clinical PET/CT with a high 
resolution half ring PET 
insert device." 
Richard Laforest, PhD, 
"Cascade calculation and 
removal for dirty PET 
nuclides." 
Joseph O'Sullivan, PhD; 
Sergey Komarov, PhD; 
Yuan-Chuan Tai, PhD, 
"System modeling of a DOI- 
capable half-ring PET insert 
device for breast cancer 
imaging." 
Yi Shu, PhD; Kooresh 
Shoghi, PhD, "R01 based 
input function estimation 
with deconvolution based 
partial volume correction for 
small animal PET dataset: a 
simulation study." 
Tae Song, PhD; Heyu Wu, 
PhD; Sergey Komarov, 
PhD; Yuan-Chuan Tai, 
PhD, "Sub-millimeter resolu- 
tion PET detector module 
using multi-pixel photon 
counter array." 
Heyu Wu, PhD; Tae Song, 
PhD; Sergey Komarov, 
PhD; Joseph O'Sullivan, 
PhD; Yuan-Chuan Tai, 
PhD, "A high resolution PET 
insert system for clinical 
PET/CT scanners." 
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In September, the 
Radiological Society of 
North America (RSNA) 
announced that Barry 
Siegel, MD, professor 
of radiology and of medicine, 
and Franz Wippold, MD, pro- 
fessor of radiology, would be 
travelling to the Socialist 
Republic of Vietnam in Sep- 
tember as part of the RSNA's 
International Visiting Profes- 
sor Program, which works 
with international radiology 
societies to assist with med- 
ical education in developing 
and newly developed nations. 
In Hanoi, Siegel and Wippold 
spoke at the 14th SEAN 
Association of Radiology 
Congress, sponsored by the 
Vietnamese Society of Radi- 
ology and Nuclear Medicine. 
Siegel and Wippold and Mar- 
ilyn Siegel, MD, professor of 
radiology and of pediatrics, 
who was an invited lecturer 
at the 14th Congress, toured 
facilities, gave lectures, and 
reviewed cases with the staff 
and residents at Bach Mai 
Hospital, Hanoi, and other 
hospitals in the northern 
province.   They also lec- 
tured at Cho Ray Hospital, 
Ho Chi Minh City (Saigon), 
and other hospitals in the 
southern province. 
PRESENTATIONS—14TH 
SEAN ASSOCIATION OF 
RADIOLOGY CONGRESS 
Barry Siegel, MD, "Current 
status of PET and PET-CT in 
clinical practice"; "PET and 
PET-CT in oncology: beyond 
FDG"; "PET and PET-CT in 
thoracic oncology"; "PET and 
PET-CT in women's cancers." 
Marilyn Siegel, MD, "CT 
angiography: congenital 
mediastinal vascular anom- 
alies;" "CT angiography: 
congenital lung lesions: 
neonates to adults"; 
"Neonatal cranial ultrasound''; 
"Ultrasound neonatal spine." 
Franz Wippold, MD, 
"Emergent viral infection,'' 
"Cerebellopontine angle 
lesions," "Cystic lesions 
of the neck," "Cervical 
lymphadenopathy." 
■==EEE 
Above: Marilyn Siegel, MD, (rig; 
answers questions from attendee 
the 14th Congress. 
Left: (left to right) Doctors Franz 
Wippold, Barry Siegel, and Eric S; 
(an RSNA visiting professor from 
Harborview Medical Center, Seat) 
Washington) at Cho Ray Hospital. 
32 MALLINCKRODT INSTITUTE OFRADIOW< 
/'Mf 
Vil 
J. *! * 
A close-up shot of the 40 illuminated spokes- 
spanning a diameter of 140 feet—forming the Ferris 
wheel at Chicago's Navy Pier. This 150-foot-high 
amusement-park ride was modeled after one built 
for Chicago's 1983 World's Columbian Exhibition. 
Photographs taken by Mickey Wynn, MIR Photography 
Lab, while attending the 94th annual RSNA meeting. 
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